Website information

Regulatory notice

Regulatory status of EXTRABROC® ingredients in the United States and China, and how to read the information on this website.

Last updated: 17 November 2026

The information on this page is provided for general reference only and does not constitute legal advice. Regulatory requirements differ between jurisdictions. Buyers must verify that their intended use complies with the laws and regulations of their own target markets.

1. United States

FDA food facility registration

The EXTRABROC® ingredient company has completed U.S. FDA food facility registration, registration No. 15731089098, registered on 2 June 2026. The registration was submitted with the assistance of our third-party compliance agent, FDAImports.com, LLC.

Clarification: food facility registration is a mandatory listing requirement for facilities that produce food for the U.S. market. It does not mean that FDA has approved, certified or endorsed any specific product, ingredient or claim.

GRAS notice

This notice refers to FDA GRAS Notice No. 496, published by the U.S. FDA, which concerns a specified broccoli seed extract as a source of glucoraphanin.

Clarification: GRAS Notice No. 496 applies only to the ingredient and conditions of use stated in the official notice. It is not an FDA approval of EXTRABROC® or of any Fushan product, and it does not mean that any EXTRABROC® model or intended use has been reviewed by FDA. Please check applicability against the official FDA notice.

Claims

Under U.S. FDA and FTC rules, finished dietary supplements made with this ingredient may carry only compliant structure/function claims and must not make claims to diagnose, treat, cure or prevent any disease. Compliance of finished-product claims is the responsibility of the finished-product manufacturer.

2. China

The glucoraphanin source used in EXTRABROC® ingredients (broccoli seed aqueous extract) is covered by China’s New Food Raw Material Announcement (2017 No. 7).

Clarification: this status applies only to the specified raw material within China, subject to the scope of use and limits set out in the announcement. It is not a regulatory approval in any other jurisdiction and does not extend to every product model or application.

3. General disclaimers

Business-to-business ingredients. EXTRABROC® ingredients are sold only to business customers qualified to manufacture foods or dietary supplements, not to consumers. They are intended for the formulation and production of finished products and are not for direct consumption or for sale to consumers as finished products.

No medical or efficacy claims. EXTRABROC® ingredients are sold as food-grade industrial ingredients. They are not intended to diagnose, treat, cure or prevent any disease or health condition, and Fushan makes no medical or efficacy promises. Nothing on this website is medical advice.

Research information. Clinical studies, scientific literature and research findings mentioned on this website are provided as scientific background only and are not a promise or endorsement of any effect of this ingredient. Some studies are investigator-initiated trials (IITs) that used a finished product as the intervention; their results cannot be assumed to apply to an EXTRABROC® ingredient. A registration describes a planned study, not a result. In their own marketing, customers must follow the regulations of their target markets and must not use content from this website to make disease-treatment or health-benefit claims; that compliance is the customer’s responsibility.

Third-party intellectual property. Third-party brand names, product marks and packaging designs shown on this website belong to their respective owners. They are shown only as examples of ingredient applications and do not imply endorsement of Fushan’s products, co-branding or a commercial partnership. EXTRABROC is a registered trademark of Shenzhen Fushan Biotech Co., Ltd. in China (classes 5 and 30) and in the European Union (class 5).

Market access. The regulatory status and company registrations described on this page do not guarantee that a product can enter, or is approved in, any target market. Buyers must complete their own compliance due diligence for each market and each finished product. For markets other than China and the United States, including requirements such as EU Novel Food or Food Standards Australia New Zealand, buyers should assess market access and ingredient compliance themselves.

Batch variation. EXTRABROC® is derived from plants, so active-component content varies within a normal range from batch to batch. Content values stated with “≥” in the specifications are minimum values. The binding specification is the one agreed in the documents for your order.

Cross-border trade. For cross-border transactions, import clearance, duties, market-access permits and related costs in the destination market are the buyer’s responsibility. Fushan can provide the supporting documents available and does not assume compliance responsibility in the importing country.

Updates. Regulatory information may change without notice. We aim to keep this page up to date but do not warrant that it is complete or accurate at any given time.

4. Privacy and cookies

How we collect and process personal data is described in our Privacy policy. Cookie settings are available under “Cookie preferences” in the website footer.

FDA statement

These statements have not been evaluated by the Food and Drug Administration. EXTRABROC® ingredients are supplied to manufacturers for further formulation and are not intended to diagnose, treat, cure, or prevent any disease.

Read the full regulatory notice

Cookie preferences

This website currently sets no analytics, advertising or tracking cookies. Your choice below is stored in your browser only and applies if optional categories are used in future.

Privacy policy